Announcement on Convening the Q3 2025 Performance Briefing
Filed with SSE · · 3 pages · Chinese
Liaoning Chengda Biotechnology Co. Ltd. on 6ix
Earlier from Liaoning Chengda Biotechnology
- Announcement on Using Partial Idle Raised Funds for Cash Management
- Announcement on Voluntary Disclosure of Signing Strategic Cooperation Agreement
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
- Announcement on the 1st Repurchase of Repurchased Shares through Call Auction
Later from Liaoning Chengda Biotechnology
- Announcement on the Postponement of Certain Fundraising Projects, Adjustment of Internal Investment Structure, and Capital Injection to Wholly-owned Subsidiaries for the Implementation of New Fundraising Subprojects
- Announcement on Adjusting the Internal Investment Structure of Partial Investment Projects Financed by Raised Funds
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Subsidiary Opening a Special Account for Raised Funds and Signing a Tripartite Supervision Agreement on Special Account Deposit of Raised Funds
- Announcement on Outward Investing in Establishing a Wholly-owned Subsidiary
Follow Liaoning Chengda Biotechnology into a list and get an email when it puts out news.
Follow Liaoning Chengda Biotechnology